Smarthub Connect™ L5 Solution

Level 5+ Pharma Traceability Infrastructure for National Regulatory Control

Medical Value Chain (MVC) Advances Pharmaceutical Traceability in Bahrain with Successful Training Sessions and Announces New App for Medicine Authentication
  • 0 Comment

Medical Value Chain (MVC) Advances Pharmaceutical Traceability in Bahrain

Manama, Bahrain – February 4, 2025 – MVC has successfully conducted a series of comprehensive training sessions for government officials, manufacturers, importers, distributors and dispensers in Bahrain. These sessions were aimed at enhancing the understanding and utilization of the upgraded NHRA-MVC Traceability Hub, ensuring compliance with Bahrain’s Legislative Decree No. 41 of 2017, which mandates a Track and Trace System for pharmaceuticals.

Training Highlights:

  • Government Compliance: Training modules focused on ensuring that government officials are well-equipped to enforce the implementation of traceability protocols, thereby maintaining the integrity of the pharmaceutical supply chain.
  • Manufacturers: Sessions included hands-on workshops on serialization, aggregation, and reporting procedures, tailored to meet the GS1 standards required by the NHRA.
  • Importers, Distributors and Dispensers: Training was provided on scanning, verification, and reporting mechanisms to facilitate seamless integration into the national traceability framework.

New App Pre-Release and Beta Testing:

MVC is excited to announce the pre-release and upcoming beta testing phase of SmartPass™ Mobile, a groundbreaking new mobile application designed to verify the authenticity of medicines. This app is set to revolutionize patient safety by providing an accessible tool for consumers, pharmacists, and healthcare providers to check the legitimacy of pharmaceutical products at the point of sale or use.

App Features:

  • Real-time Authentication: Users can scan medicine packaging to verify its authenticity against the NHRA-MVC Traceability Hub database.
  • User-Friendly Interface: Designed for ease of use, ensuring that verification can be conducted swiftly and accurately.
  • Security Enhancements: Incorporates advanced security measures, leveraging MVC’s patent pending blockchain technologies, to protect against counterfeit drugs, aligning with Bahrain’s commitment to public health safety.

Statements:

  • Shaikha Dheya Bint Ebrahim Al Khalifa, MVC Executive Chairperson, stated, “Our commitment to enhancing the safety and efficiency of Bahrain’s pharmaceutical supply chain is reflected in these training sessions. The introduction of our new authentication app is a testament to our ongoing innovation in healthcare technology.”

MVC remains dedicated to fostering a transparent, secure, and efficient pharmaceutical supply chain in Bahrain, ensuring that all parties are well-informed and equipped to adapt to the evolving landscape of pharmaceutical traceability.

MVC remains dedicated to fostering a transparent, secure, and efficient pharmaceutical supply chain in Bahrain

• Shaikha Dheya Bint Ebrahim Al Khalifa, MVC Executive Chairperson, stated, "Our commitment to enhancing the safety and efficiency of Bahrain's pharmaceutical supply chain is reflected in these training sessions.

For more information, please contact:

MVC Communications
Email: info@avc360.com (mailto:info@avc360.com)
Phone: +973 1704 4777

 

en_USEN